It is well known that cancer proliferation, invasion, and metastasis are inseparable from angiogenesis, and VEGF is the most effective regulator in this process.[24] As early as 2002,[25] studies have reported that VEGF overexpression is correlated with angiogenesis and poor prognosis of patients with endometrial cancer. This evidence concerns the gene VEGFA and endometrial cancer.